| Literature DB >> 27689239 |
Farah H Amro1, Hind N Moussa2, Olaide A Ashimi2, Baha M Sibai2.
Abstract
INTRODUCTION: Hypertensive disorders have become increasingly prevalent and complicate an increasing number of pregnancies. Therefore it is essential that the medications used to treat these disorders be well understood. Furthermore the management is complicated by special consideration needed for the physiologic changes of pregnancy as well as the consideration for possible adverse fetal effects. Areas covered: We performed a review of the scientific literature of medications used to treat hypertensive disorders in pregnancy. We reviewed the guidelines used by different societies all over the world. We also discussed the pharmacodynamics, pharmacokinetics and possible adverse effects relating to the antihypertensive medications. Finally, we discussed the long-term maternal implications of these diseases. Expert opinion: Overall, we encourage a step-wise approach to treating hypertensive disorders of pregnancy. While making sure to max out the use of one medications prior to shifting to another. Also, it is imperative not to be aggressive with treatment due to risk of compromising utero-placental blood flow. There is research currently involving biomarkers, nano-medicine and the placenta project with hopes of developing new targeted medications with a good fetal safety profile.Entities:
Keywords: Antihypertensives; chronic hypertension; drugs; gestational hypertension; labetalol; methyldopa; nifedipine; preeclampsia; preeclampsia with severe features; pregnancy; teratogenesis
Mesh:
Substances:
Year: 2016 PMID: 27689239 DOI: 10.1080/14740338.2016.1237500
Source DB: PubMed Journal: Expert Opin Drug Saf ISSN: 1474-0338 Impact factor: 4.250